News & Updates
Showing Oncology articles
Showing
Anaemia in half, iron deficiency in fifth of HK patients with advanced prostate cancer
Anaemia affects 52.4 percent, while iron deficiency is present in 20.7 percent of Hong Kong patients with advanced prostate cancer (CaP), according to findings from a local cohort.
Anaemia in half, iron deficiency in fifth of HK patients with advanced prostate cancer
22 Apr 2025
3-year RUBY data support add-on dostarlimab as frontline Tx for endometrial cancer
At the second interim analysis of part 1 of the phase III RUBY study, updated duration of response (DoR) findings suggest that women with primary advanced or recurrent endometrial cancer who have achieved a response with the combination regimen comprising dostarlimab and carboplatin-paclitaxel (CP) have substantially improved DoR.
3-year RUBY data support add-on dostarlimab as frontline Tx for endometrial cancer
17 Apr 2025
Testosterone recovery after ADT tied to improved OS in prostate cancer
Testosterone recovery to a normal level appears predictive of improved overall survival (OS) among men with intermediate-risk prostate cancer who underwent androgen-deprivation therapy (ADT) and radiation therapy (RT), suggests a study.
Testosterone recovery after ADT tied to improved OS in prostate cancer
16 Apr 2025
TB vax primer augments BCG-induced immune response in bladder cancer patients
Initial results of the phase I RUTIVAC-1 study show the potential of two doses of a tuberculosis (TB) vaccine given after surgery but before standard BCG* treatment to boost immunity and reduce the odds of recurrence in patients with non-muscle-invasive bladder cancer (NMIBC).
